ESR1 and neoplasm: One study demonstrated that the administration of oxytocin reduces tumor growth through the reduction in the expression of proteins of the signaling pathways involved in cell proliferation and induction, such as Akt and ERK, and also through the inhibition of estrogen receptor (ER) expression [35].